Literature DB >> 8825567

Chemoimmunotherapy of canine lymphoma with adjuvant canine monoclonal antibody 231.

K A Jeglum1.   

Abstract

Chemoimmunotherapy with adjuvant CL/MAb 231 offers an alternative treatment approach for canine lymphoma. Results of treatment and prognostic factors are discussed and compared with previously published chemotherapy results.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8825567     DOI: 10.1016/s0195-5616(96)50007-0

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  1 in total

1.  Multicentric canine lymphoma in a 12-year-old keeshond: chemotherapy options.

Authors:  Mireille M C Martineau
Journal:  Can Vet J       Date:  2002-09       Impact factor: 1.008

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.